Updated review of advances in microRNAs and complex diseases: experimental results, databases, webservers and data fusion
MicroRNAs (miRNAs) are gene regulators involved in the pathogenesis of complex
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …
diseases such as cancers, and thus serve as potential diagnostic markers and therapeutic …
The microRNA-183 cluster: the family that plays together stays together
S Dambal, M Shah, B Mihelich, L Nonn - Nucleic acids research, 2015 - academic.oup.com
Abstract The microRNA (miR) 183 cluster, which is comprised of miRs-183,-96 and-182, is
also a miR family with sequence homology. Despite the strong similarity in the sequences of …
also a miR family with sequence homology. Despite the strong similarity in the sequences of …
[HTML][HTML] Integrative analysis of long extracellular RNAs reveals a detection panel of noncoding RNAs for liver cancer
Y Zhu, S Wang, X Xi, M Zhang, X Liu, W Tang, P Cai… - Theranostics, 2021 - ncbi.nlm.nih.gov
Abstract Rationale: Long extracellular RNAs (exRNAs) in plasma can be profiled by new
sequencing technologies, even with low abundance. However, cancer-related exRNAs and …
sequencing technologies, even with low abundance. However, cancer-related exRNAs and …
The translational potential of microRNAs as biofluid markers of urological tumours
A Fendler, C Stephan, GM Yousef… - Nature Reviews …, 2016 - nature.com
MicroRNAs (miRNAs) are secreted by cells in vesicles, bound in a ribonucleoprotein
complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer …
complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer …
[HTML][HTML] miRNAs as novel biomarkers in the management of prostate cancer
X Filella, L Foj - Clinical Chemistry and Laboratory Medicine (CCLM), 2017 - degruyter.com
Abstract microRNAs (miRNAs) are small non-coding RNAs that control gene expression
posttranscriptionally and are part of the giant non codifying genoma. Cumulating data …
posttranscriptionally and are part of the giant non codifying genoma. Cumulating data …
[HTML][HTML] The genomic impact of DNA CpG methylation on gene expression; relationships in prostate cancer
The process of DNA CpG methylation has been extensively investigated for over 50 years
and revealed associations between changing methylation status of CpG islands and gene …
and revealed associations between changing methylation status of CpG islands and gene …
[HTML][HTML] The utility of urine-circulating miRNAs for detection of prostate cancer
K Stuopelyte, K Daniunaite, A Bakavicius… - British journal of …, 2016 - nature.com
Background: In this paper, the utility of urine-circulating microRNAs (miRNAs) as the
potential biomarker of prostate cancer (PCa), the second most prevalent male cancer …
potential biomarker of prostate cancer (PCa), the second most prevalent male cancer …
A 9-microRNA signature in serum serves as a noninvasive biomarker in early diagnosis of Alzheimer's disease
R Guo, G Fan, J Zhang, C Wu, Y Du… - Journal of …, 2017 - content.iospress.com
Alzheimer's disease (AD) is the most common type of age-related neurodegenerative
disorder; nevertheless, nowadays there are no reliable biomarkers or non-invasive …
disorder; nevertheless, nowadays there are no reliable biomarkers or non-invasive …
[HTML][HTML] Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
Metastatic castration resistant prostate cancer (mCRPC) is associated with high mortality,
where monitoring of disease activity is still a major clinical challenge. The role of microRNAs …
where monitoring of disease activity is still a major clinical challenge. The role of microRNAs …
Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis
MYC Stafford, CE Willoughby, CP Walsh… - Bioscience …, 2022 - portlandpress.com
Elevated levels of miR-21 expression are associated with many cancers, suggesting it may
be a promising clinical biomarker. In prostate cancer (PCa), however, there is still no …
be a promising clinical biomarker. In prostate cancer (PCa), however, there is still no …